Home

• Research Areas

  • Prevention
  • Detection/Screening
  • Symptom Science
  • Networks, Consortia & Programs

• Key Info

  • Funding Opportunities
  • Funded Grants List
  • Clinical Trials List
  • Statistical Programs

Featured Updates

• 
  PLCO Trial Leaves Legacy Through Data

  NCI announced an ambitious cancer screening trial to find answers about the utility of cancer screening tests in preventing deaths from four types of cancer.

• 
  NCI Selects Two Assays for the Vanguard Study on Multi-Cancer Detection Tests

  NCI has selected two assays to be included in the Vanguard Study: Avantect® Multi-Cancer Detection Test by ClearNote Health and Shield™ Multi-Cancer Detection Test by Guardant Health.

• 
  Building Bridges in Cancer Symptom Science Webinar Series

  This series is aimed at bringing together interdisciplinary researchers in cancer symptom science to share their expertise and further discussions in the field.